Platinum sponsorS


In the field of neuroscience, with many tough-to-treat disorders and high unmet need, our scientists are relentless in their pursuit of raising the standards of care. But the brain is complex, and new challenges require new ways of thinking across all stages of drug discovery and development.

That’s why we are continuously exploring innovative, disease-modifying approaches to address some of the most prevalent and serious disorders, from Parkinson’s and Alzheimer’s to migraine, schizophrenia and stroke.

We work across all stages of development in search of novel therapeutics and drug-device combinations that have the potential to treat chronic disabling neurological and psychiatric conditions.

Boehringer Ingelheim

We have made a long-term, generational commitment to transform the mental health landscape through our research and collaborations with a variety of like-minded stakeholders. By taking a strategic and intentional precision psychiatry approach, our hope is to design treatments that have the potential to address the brain biology associated with specific symptoms.

Our innovative pipeline of owned and partnered assets represents potential opportunities to make precision psychiatry a reality in indications of high unmet need and sits at the core of our ambition to create a deeper understanding of the drivers of chronic and complex mental health conditions. We go beyond the idea that mental health treatment is just a pill and are driven to provide holistic support through early detection of disease, ongoing psychological and social interventions, as well as prescription digital therapeutics.

We strive to alleviate the burden on people living with mental health conditions, their care partners, loved ones and society.


Pfizer is at the forefront of research and innovation in the field of brain health. With a strong commitment to advancing neurological science, Pfizer is dedicated to discovering transformative therapies for neurological disorders such as Alzheimer’s disease, epilepsy, and migraine.

Through their extensive research and development efforts, Pfizer aims to unlock new treatment options that can improve the lives of patients worldwide. They collaborate with leading scientists, academic institutions, and healthcare professionals to drive scientific discovery and bring innovative solutions to the forefront.

Pfizer’s commitment to brain health extends beyond scientific advancements. They actively engage with patient communities, advocate for greater awareness, and provide support to those affected by neurological conditions. With a compassionate approach and a focus on improving patient outcomes, Pfizer is paving the way for a brighter future in brain health.